16. April 2016

Promising News at Lipocalyx

Lipocalyx, a German biotech company in the field of non-viral transfection reagents, has been developing in a very impressive way since its foundation about five years ago.

Four different product lines were established all of which show excellent transfecting properties.

Their superiority compared to competing products did not only result in rising worldwide sales figures but also in more than 20 top-notch publications of scientists who managed to even address hardly accessible cells such as mesenchymal stem cells, macrophages, monocytes, myoblasts and hepatocytes (also refer to www.lipocalyx.de).

Two weeks ago, lipocalyx closed a new deal with financial investors supporting the further growth of the company. ChiroBlock doesn’t only support this company by providing sophisticated compounds but we are also a co-founding partner right from the beginning. We are proud of the lipocalyx team and very much appreciate the fruitful co-operation between our two companies.

contact us

Cookie Setting: We use Cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our coporate commercial objectives, as well as other cookies which are used soley for anonymous statistical purposes, for more comfortable website settings, or for the display of personal content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. You can always opt-out of our cookie settings. Further information can be found in our data policy.